Similar Search Results

The effects of product liability exemption in the presence of the FDA

Philipson, Tomas J.; Sun, Eric; Goldman, Dana P. - In: Regulation versus litigation : perspectives from …, (pp. 137-163). 2011

Persistent link: https://www.econbiz.de/10009236132

A reexamination of the costs of medical R&D regulation

Philipson, Tomas J.; Sun, Eric; Goldman, Dana P.; Jena, … - In: Forum for health economics & policy : an evolving … 15 (2012) 3, pp. 132-159

Persistent link: https://www.econbiz.de/10009656216

Opportunities for improving the drug development process : results from a survey of industry and the FDA

Berndt, Ernst R.; Gottschalk, Adrian H. B.; Strobeck, … - In: Innovation policy and the economy 6 (2006), pp. 91-121

Persistent link: https://www.econbiz.de/10003375038

Opportunities for improving the drug development process : results from a survey of industry and the FDA

Berndt, Ernst R.; Gottschalk, Adrian H. B.; Strobeck, … - 2005

Persistent link: https://www.econbiz.de/10002945129

Opportunities for Improving the Drug Development Process : Results from a Survey of Industry and the FDA

Berndt, Ernst R. - 2005

Based on our survey and discussions, we uncovered several thematic opportunities to improve interactions between the FDA and industry and to reduce clinical development times: 1) develop metrics and goals at the FDA for clinical development times in exchange for PDUFA like fees; 2) establish an...

Persistent link: https://www.econbiz.de/10012467254